
Viemed Healthcare VMD
$ 8.45
1.93%
Quarterly report 2025-Q3
added 11-05-2025
Viemed Healthcare DSO Ratio 2011-2026 | VMD
Annual DSO Ratio Viemed Healthcare
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.7 | 37.1 | 39.3 | 34.4 | 52.5 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 52.5 | 33.7 | 39.4 |
Quarterly DSO Ratio Viemed Healthcare
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.2 | 38.6 | 39.9 | - | 42.6 | 42.8 | 38.7 | - | 33.1 | 36 | 36.6 | - | 19.1 | 18.6 | 37.4 | - | 38.7 | 42.3 | 41.2 | 36.2 | 33.8 | 26.4 | 45.8 | 49.1 | 51.7 | 51.8 | 51.3 | 43.9 | 47.6 | 58.6 | 34.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 58.6 | 18.6 | 39.7 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
85.8 | $ 3.92 | -1.51 % | $ 136 M | ||
|
Alphatec Holdings
ATEC
|
46.4 | $ 13.47 | -3.09 % | $ 1.93 B | ||
|
Cognyte Software Ltd.
CGNT
|
72 | $ 7.2 | -6.13 % | $ 517 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Bio-Rad Laboratories
BIO
|
66.9 | $ 293.69 | -2.09 % | $ 8.29 B | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 42.43 | 2.04 % | $ 6.32 K | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
CONMED Corporation
CNMD
|
67 | $ 42.33 | - | $ 1.31 B | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 73.47 | - | $ 108 B | ||
|
Abbott Laboratories
ABT
|
58.7 | $ 113.59 | - | $ 198 B | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
46.1 | $ 13.37 | - | $ 361 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 4.9 | 6.52 % | $ 183 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
137 | $ 25.26 | - | $ 214 M | ||
|
InMode Ltd.
INMD
|
5.36 | $ 14.24 | -2.6 % | $ 1.13 B | ||
|
IRadimed Corporation
IRMD
|
56.8 | $ 103.08 | -1.97 % | $ 1.31 B | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
237 | $ 18.58 | -0.69 % | $ 122 M | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
Integer Holdings Corporation
ITGR
|
50.7 | $ 87.18 | 1.2 % | $ 2.93 B | ||
|
Globus Medical
GMED
|
76.9 | $ 88.26 | -0.52 % | $ 12 B | ||
|
Pulmonx Corporation
LUNG
|
54.9 | $ 1.45 | - | $ 56.7 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 11.18 | 1.82 % | $ 861 M | ||
|
Establishment Labs Holdings
ESTA
|
123 | $ 72.72 | 0.19 % | $ 2.05 B | ||
|
Medigus Ltd.
MDGS
|
29.4 | - | 10.28 % | $ 55.5 M | ||
|
IRIDEX Corporation
IRIX
|
45.6 | $ 1.43 | - | $ 23.1 M | ||
|
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | ||
|
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.62 | -7.43 % | $ 33.7 M |